Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thereasa Rich

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer|October 19, 2011
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experienceMontserrat Ayala-Ramirez, Lei Feng, Mouhammed A Habra, et al.
Genes, Chromosomes & Cancer|November 19, 2013
Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new casesRobert Pilarski, Colleen M Cebulla, James B Massengill, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2013
The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2Sonali Thosani, Montserrat Ayala-Ramirez, Lynn Palmer, et al.
Familial Cancer|November 20, 2016
All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patientsKristin L Long, Carol Etzel, Thereasa Rich, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2010
Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicatorsMontserrat Ayala-Ramirez, Lei Feng, Marcella M Johnson, et al.
World Journal of Surgery|January 7, 2014
Impact of surgical resection for subdiaphragmatic paragangliomasShabirhusain S Abadin, Montserrat Ayala-Ramirez, Camilo Jimenez, et al.
The Oncologist|June 22, 2021
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning PlatformEdwin Lin, Andrew W Hahn, Roberto H Nussenzveig, et al.
BMC Cancer|March 21, 2023
ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)Susanna Slater, Annette Bryant, Hsiang-Chi Chen, et al.
Breast Cancer Research and Treatment|November 21, 2020
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)Katherine Clifton, Jingqin Luo, Yu Tao, et al.
Clinical and Translational Science|March 12, 2025
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC ConsortiumAndrew G Hadd, Angela Silvestro, Brittany Avin McKelvey, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer|October 19, 2011
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experienceMontserrat Ayala-Ramirez, Lei Feng, Mouhammed A Habra, et al.
Genes, Chromosomes & Cancer|November 19, 2013
Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new casesRobert Pilarski, Colleen M Cebulla, James B Massengill, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2013
The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2Sonali Thosani, Montserrat Ayala-Ramirez, Lynn Palmer, et al.
Familial Cancer|November 20, 2016
All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patientsKristin L Long, Carol Etzel, Thereasa Rich, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2010
Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicatorsMontserrat Ayala-Ramirez, Lei Feng, Marcella M Johnson, et al.
World Journal of Surgery|January 7, 2014
Impact of surgical resection for subdiaphragmatic paragangliomasShabirhusain S Abadin, Montserrat Ayala-Ramirez, Camilo Jimenez, et al.
The Oncologist|June 22, 2021
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning PlatformEdwin Lin, Andrew W Hahn, Roberto H Nussenzveig, et al.
BMC Cancer|March 21, 2023
ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)Susanna Slater, Annette Bryant, Hsiang-Chi Chen, et al.
Breast Cancer Research and Treatment|November 21, 2020
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)Katherine Clifton, Jingqin Luo, Yu Tao, et al.
Clinical and Translational Science|March 12, 2025
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC ConsortiumAndrew G Hadd, Angela Silvestro, Brittany Avin McKelvey, et al.
Pageof 3